Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
89bio, Inc is a biotechnology business based in the US. 89bio shares (ETNB) are listed on the NASDAQ and all prices are listed in US Dollars. 89bio employs 25 staff and has a market cap (total outstanding shares value) of USD$540.5 million.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Mobile users
Latest market close | USD$25.97 |
---|---|
52-week range | USD$14.0001 - USD$47.2532 |
50-day moving average | USD$26.5882 |
200-day moving average | USD$28.1874 |
Wall St. target price | USD$59.88 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-4.5598 |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $25.97 from 2020-12-18
1 week (2021-01-15) | 21.47% |
---|---|
1 month (2020-12-23) | -2.88% |
3 months (2020-10-22) | 6.17% |
6 months (2020-07-22) | -21.64% |
1 year (2020-01-22) | -7.94% |
---|---|
2 years (2019-01-19) | N/A |
3 years (2018-01-19) | N/A |
5 years (2016-01-19) | N/A |
Gross profit TTM | USD$0 |
---|---|
Return on assets TTM | -24% |
Return on equity TTM | -49.78% |
Profit margin | 0% |
Book value | N/A |
Market capitalisation | USD$540.5 million |
TTM: trailing 12 months
There are currently 539,056 89bio shares held short by investors – that's known as 89bio's "short interest". This figure is 4.1% down from 561,819 last month.
There are a few different ways that this level of interest in shorting 89bio shares can be evaluated.
89bio's "short interest ratio" (SIR) is the quantity of 89bio shares currently shorted divided by the average quantity of 89bio shares traded daily (recently around 136816.24365482). 89bio's SIR currently stands at 3.94. In other words for every 100,000 89bio shares traded daily on the market, roughly 3940 shares are currently held short.
However 89bio's short interest can also be evaluated against the total number of 89bio shares, or, against the total number of tradable 89bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case 89bio's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 89bio shares in existence, roughly 30 shares are currently held short) or 0.0535% of the tradable shares (for every 100,000 tradable 89bio shares, roughly 54 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against 89bio.
Find out more about how you can short 89bio stock.
We're not expecting 89bio to pay a dividend over the next 12 months.
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop BIO89-100 for the treatment of severe hypertriglyceridemia. 89bio, Inc. was founded in 2018 and is based in San Francisco, California.
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.